Second chance: repeat islet transplants tested for type 1 diabetes
NCT ID NCT07666789
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a second islet transplant can safely improve blood sugar control in adults with type 1 diabetes whose first transplant stopped working. Researchers will follow 20 patients for up to 5 years, checking graft function, insulin use, and severe low blood sugar events. The goal is to understand if re-transplantation is worth the risks, including possible immune reactions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
islet cells (from donor pancreas)
What this could lead to
If successful, this could show that a second islet transplant helps people with type 1 diabetes regain blood sugar control after the first transplant stops working.
What could go wrong
This is a small, retrospective study (20 people) that looks back at past data, not a controlled trial. Repeated transplants may increase immune reactions that could harm the new graft.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Montpellier University Hospital
RECRUITINGMontpellier, 34000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact